This HTML5 document contains 138 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45262881
rdf:type
wikibase:Item
schema:description
articol științific ശാസ്ത്രപ്രബന്ധം​ tudományos cikk научная статья 2005年學術文章 2005年学术文章 სამეცნიერო სტატია scienca artikolo мақолаи илмӣ scientific article published in February 2005 wetenschappelijk artikel ফেব্রুয়ারি ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico 2005年學術文章 vitskapeleg artikkel مقالة علمية نشرت في فبراير 2005 article scientific vetenskaplig artikel 2005年学术文章 bilimsel makale научни чланак tieteellinen artikkeli artigo científico teaduslik artikkel บทความทางวิทยาศาสตร์ artikull shkencor scientific article published in February 2005 2005 nî lūn-bûn vědecký článek 2005年學術文章 наукова стаття, опублікована в лютому 2005 επιστημονικό άρθρο artículo científico publicado en 2005 научни чланак artykuł naukowy 2005年学术文章 artigo científico 2005年學術文章 article scientifique artículu científicu articolo scientifico מאמר מדעי 2005年学术文章 wissenschaftlicher Artikel научна статия artikulong pang-agham artikel ilmiah videnskabelig artikel bài báo khoa học 2005年の論文 naučni članak vedecký článok 2005년 논문 2005年学术文章 2005年學術文章 2005年学术文章 vitenskapelig artikkel article científic scientific article published in February 2005
p:P577
wds:Q45262881-C81B7455-A7FF-4F5C-8E29-C21781E81ECB
wdt:P577
2005-02-01T00:00:00Z
p:P407
wds:Q45262881-CE86BC4B-0CF7-4D91-8608-25E8B8EF423E
wdt:P407
wd:Q1860
p:P2860
wds:Q45262881-BFD4F9A6-9B63-4760-8AEB-F9BAF07CEA42 wds:Q45262881-54FB396B-DE30-4422-824A-A7D84D074844 wds:Q45262881-604B70FD-7AC0-4EE4-9464-33E42AFD1E17 wds:Q45262881-8E4B3266-8729-4229-85FB-C587D44A3A73 wds:Q45262881-90CF0D72-8C9E-4F2B-A73B-54C0F758EBEF wds:Q45262881-134E16C7-A778-4122-9E19-24C6C2D3FEB9 wds:Q45262881-231D287E-B58D-4180-A83C-292F0DC4EE09 wds:Q45262881-23347A22-B3EC-4D72-84C2-798BE9EBF0B3 wds:Q45262881-2AC91376-E19A-404F-9753-BF3766B4860C wds:Q45262881-4378AACE-B042-42DF-B6C0-B983ED90E9D5 wds:Q45262881-49FE9FAB-CDFA-4519-8D31-2BB8B2518CD4 wds:Q45262881-4E73FB62-74B5-4FDE-9964-9D19D2BD477D wds:Q45262881-10FEB36F-9175-41AC-AE83-25DABE62A03E wds:Q45262881-DA5FB592-F0DB-4BFF-AC2C-1D58908F4E3D wds:Q45262881-DD1C7CEF-16FC-452E-A00C-19E68C058A81 wds:Q45262881-F9BA5273-146B-4B4E-A3E9-01F74BD033DE
wdt:P2860
wd:Q43861090 wd:Q43028674 wd:Q71605414 wd:Q73330360 wd:Q35259780 wd:Q41091925 wd:Q22306318 wd:Q43897091 wd:Q61912454 wd:Q43420119 wd:Q41873557 wd:Q77377382 wd:Q46169372 wd:Q38719109 wd:Q68172132 wd:Q34290556
p:P2093
wds:Q45262881-0FDE9146-6BAB-43B6-A978-B1E649FDF4BE wds:Q45262881-9095F838-F0A5-4FCB-83FF-212764B5AFF5 wds:Q45262881-6E5C8BAF-3869-4C07-B9A4-D495DB4BD468 wds:Q45262881-D54EB619-1AED-4F85-BCE2-42EA0557F505 wds:Q45262881-CCDCCE5C-E586-4701-9689-6D827DFE41E1 wds:Q45262881-BF5D350A-76D1-4B3A-8344-2F5B67CB132A wds:Q45262881-B0FD387A-8773-4325-9332-72A7EBFF2EF3
wdt:P2093
Pauline Hyman-Taylor David Stableforth TOPIC Study Group Kelvin H-V Tan Michael Mulheran Alan Prof Knox Sarah Lewis
rdfs:label
Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial
skos:prefLabel
Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial
schema:name
Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial
p:P50
wds:Q45262881-0E18D5BD-2058-489A-9FE9-6A970EEF30A9
wdt:P50
wd:Q40855569
p:P1476
wds:Q45262881-AEF12BA3-1991-4D1B-A027-7DDFEA5961C8
wdt:P1476
Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial
p:P304
wds:Q45262881-BD60F38B-99B0-4CC5-B88A-297C6410E95B
wdt:P304
573-578
p:P31
wds:Q45262881-7CD28A7A-91E9-4016-AD64-327E6966B756
wdt:P31
wd:Q13442814
p:P921
wds:Q45262881-5BD9624A-4C92-4EF6-A8E9-4DCCAE3C7ED5
wdt:P921
wd:Q178194
p:P698
wds:Q45262881-11CF1F9E-29A0-41D9-B999-438B10B75C67
wdtn:P698
n10:15708100
wdt:P698
15708100
p:P1433
wds:Q45262881-A1AEBD7C-9703-4EFD-8992-7F33BF383C47
wdt:P1433
wd:Q939416
p:P433
wds:Q45262881-CFAE7C45-37FC-4676-8DE7-712F37AF3792
p:P478
wds:Q45262881-1F11FF0F-81FE-4FF7-A536-910014CF2B24
wdt:P433
9459
wdt:P478
365
p:P356
wds:Q45262881-E3CB346E-CA4E-409E-B926-C55012543F09
wdtn:P356
n11:S0140-6736(05)17906-9
wdt:P356
10.1016/S0140-6736(05)17906-9